Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study

Authors:
  • AKAkihito Kawazoe
    Akihito Kawazoe
  • SMSaori Mishima
    Saori Mishima
  • TWTatsuya Wada
    Tatsuya Wada
  • TSTakuro Shimbo
    Takuro Shimbo
  • KSKatsunori Sekine
    Katsunori Sekine
  • KWKazuhiro Watanabe
    Kazuhiro Watanabe
  • KIKoh Imbe
    Koh Imbe
  • YKYasushi Kojima
    Yasushi Kojima
  • KKKeigo Kumazawa
    Keigo Kumazawa
  • FMFuminori Mihara
    Fuminori Mihara
  • MTMakoto Tokuhara
    Makoto Tokuhara

Abstract
Patients with main duct (MD) intraductal papillary mucinous neoplasms (IPMNs) have a greater risk of developing pancreatic cancer and consequent death than patients without MD-IPMNs; however, cyst size was not associated with these outcomes. Purpose To determine the cumulative incidence, disease-specific mortality, and all-cause mortality of pancreatic cancer (PC) in patients with intraductal papillary mucinous neoplasms (IPMNs) and to identify imaging findings that are associated with these outcomes. Materials and Methods This retrospective study had institutional review board approval, and the need to obtain patient consent was waived. Data from an electronic database were analyzed and supplemented by chart reviews for 285 patients with nonresected IPMNs who were periodically followed up with imaging (1273 multidetector computed tomography and 750 magnetic resonance cholangiopancreatography examinations). The Kaplan-Meier method was used to estimate the cumulative development of PC, PC mortality, and all-cause mortality (factors were compared by using the log-rank test). Results Over a median imaging follow-up period of 39 months, 12 (4.2%) of 285 patients developed PC; the cumulative 5-year PC incidence was 3.9% for branch duct (BD)-IPMNs,...

This publication has 30 references indexed in Scilit: